COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia

Alessandro Bertolino, Grazia Caforio, Giuseppe Blasi, Antonio Rampino, Lorenzo Sinibaldi, Sophia Douzgou, Marcello Nardini, Daniel R. Weinberger, Bruno Dallapiccola

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)253-255
Number of pages3
JournalSchizophrenia Research
Volume95
Issue number1-3
DOIs
Publication statusPublished - Sep 2007

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Bertolino, A., Caforio, G., Blasi, G., Rampino, A., Sinibaldi, L., Douzgou, S., Nardini, M., Weinberger, D. R., & Dallapiccola, B. (2007). COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia. Schizophrenia Research, 95(1-3), 253-255. https://doi.org/10.1016/j.schres.2007.06.014